PDLIM7 and systemic lupus erythematosus: These suggest EBV might involve in the SLE development and progression through cross-reactivity of EBV EA (FEVSPDAVAEWQNHQ-Epitope 1, YKRPQGCS-Epitope 2, PPPPPRTP-Epitope 4), LMP-1 (LVSGAGDGPP-Epitope 6), and LMP-2A (GLALSL-Epitope 10) B-cell epitopes with SLE self-antigens.